KMG Fiduciary Partners LLC Has $9.46 Million Position in Cardinal Health, Inc. (NYSE:CAH)

KMG Fiduciary Partners LLC raised its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 2.8% during the 4th quarter, HoldingsChannel reports. The firm owned 79,977 shares of the company’s stock after purchasing an additional 2,141 shares during the quarter. KMG Fiduciary Partners LLC’s holdings in Cardinal Health were worth $9,459,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of CAH. Paragon Capital Management Inc. boosted its stake in Cardinal Health by 0.7% during the 2nd quarter. Paragon Capital Management Inc. now owns 14,758 shares of the company’s stock valued at $1,451,000 after purchasing an additional 99 shares during the period. Huntington National Bank lifted its holdings in shares of Cardinal Health by 0.9% during the third quarter. Huntington National Bank now owns 10,792 shares of the company’s stock worth $1,193,000 after buying an additional 100 shares during the last quarter. Blair William & Co. IL boosted its position in shares of Cardinal Health by 0.9% in the second quarter. Blair William & Co. IL now owns 11,442 shares of the company’s stock valued at $1,125,000 after acquiring an additional 103 shares during the period. Frazier Financial Advisors LLC grew its stake in shares of Cardinal Health by 69.8% in the third quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock worth $28,000 after acquiring an additional 104 shares during the last quarter. Finally, UMB Bank n.a. grew its stake in shares of Cardinal Health by 4.9% in the third quarter. UMB Bank n.a. now owns 2,249 shares of the company’s stock worth $249,000 after acquiring an additional 106 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Stock Performance

Shares of NYSE CAH opened at $127.03 on Friday. The business has a fifty day moving average of $120.63 and a two-hundred day moving average of $111.61. Cardinal Health, Inc. has a 52-week low of $93.17 and a 52-week high of $127.08. The stock has a market cap of $30.74 billion, a PE ratio of 24.71, a PEG ratio of 1.48 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Friday, November 1st. The company reported $1.88 EPS for the quarter, beating analysts’ consensus estimates of $1.62 by $0.26. The firm had revenue of $52.28 billion for the quarter, compared to analyst estimates of $50.90 billion. Cardinal Health had a net margin of 0.56% and a negative return on equity of 56.56%. The company’s revenue for the quarter was down 4.3% compared to the same quarter last year. During the same period in the previous year, the business earned $1.73 earnings per share. Analysts predict that Cardinal Health, Inc. will post 7.82 earnings per share for the current year.

Cardinal Health Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd were given a dividend of $0.5056 per share. The ex-dividend date was Thursday, January 2nd. This represents a $2.02 dividend on an annualized basis and a yield of 1.59%. Cardinal Health’s dividend payout ratio (DPR) is presently 39.30%.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the stock. Morgan Stanley upped their target price on shares of Cardinal Health from $127.00 to $136.00 and gave the company an “overweight” rating in a research note on Tuesday, December 17th. StockNews.com lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd. UBS Group lifted their target price on Cardinal Health from $134.00 to $139.00 and gave the stock a “buy” rating in a research report on Monday, November 4th. Deutsche Bank Aktiengesellschaft boosted their price target on Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Finally, Mizuho started coverage on Cardinal Health in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $139.00 price objective for the company. Four investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $133.29.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.